Is 300 Seconds ACT Safe and Efficient during MiECC Procedures?
Conclusion Since no evidence of increased thrombin formation (ETP) was found from a laboratory standpoint, we concluded that the use of MiECC with a reduced anticoagulation strategy seems possible. This alternative anticoagulation strategy leads to significant reduction in dosages of both heparin and protamine. We can confidently move forward with investigating this anticoagulation concept. However, to establish clinical safety of ACT below 300 seconds, we need larger clinical studies. [...] Georg Thieme Verlag KG Stuttgart · New YorkArticle in Thieme eJournals: Table of contents | Abstract | Full text
Source: The Thoracic and Cardiovascular Surgeon - Category: Cardiovascular & Thoracic Surgery Authors: Bauer, Adrian Hausmann, Harald Schaarschmidt, Jan Szlapka, Michal Scharpenberg, Martin Eberle, Thomas Hasenkam, J. Michael Tags: Original Cardiovascular Source Type: research
More News: Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Coronary Artery Bypass Graft | Heart | Laboratory Medicine | Study